tiprankstipranks
Advertisement
Advertisement

RLMD Stock Latest News

Relmada Therapeutics joins Russell 2000, Russell 3000 Indexes
The FlyRelmada Therapeutics joins Russell 2000, Russell 3000 Indexes
6h ago
RLMD
Relmada Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Relmada Therapeutics initiated with a Buy at H.C. Wainwright
11d ago
RLMD
Relmada Therapeutics Increases Authorized Shares After Shareholder Vote
PremiumCompany Announcements
Relmada Therapeutics Increases Authorized Shares After Shareholder Vote
1M ago
8K
RLMD
Relmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
PremiumCompany Announcements
Relmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
2M ago
RLMD
Relmada Therapeutics files automatic mixed securities shelf
PremiumThe Fly
Relmada Therapeutics files automatic mixed securities shelf
2M ago
RLMD
Relmada Highlights NDV-01 Phase 2 Data, Phase 3 Plans
PremiumCompany AnnouncementsRelmada Highlights NDV-01 Phase 2 Data, Phase 3 Plans
2M ago
8K
RLMD
Relmada Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Relmada Therapeutics initiated with an Overweight at Piper Sandler
3M ago
RLMD
Relmada Therapeutics Charts Aggressive Path After Earnings Call
Premium
Company Announcements
Relmada Therapeutics Charts Aggressive Path After Earnings Call
3M ago
RLMD
Relmada Highlights NDV-01 Data, Funding in 2025 Results
PremiumCompany Announcements
Relmada Highlights NDV-01 Data, Funding in 2025 Results
3M ago
8K
RLMD
Relmada Therapeutics price target raised to $19 from $10 at Mizuho
PremiumThe Fly
Relmada Therapeutics price target raised to $19 from $10 at Mizuho
3M ago
RLMD
Relmada’s Withdrawn Phase 3 Bladder Cancer Trial: What It Means for RLMD Investors
PremiumCompany Announcements
Relmada’s Withdrawn Phase 3 Bladder Cancer Trial: What It Means for RLMD Investors
3M ago
RLMD
Relmada’s Withdrawn BOOST Trial Resets Expectations for NDV-01 and RLMD
PremiumCompany Announcements
Relmada’s Withdrawn BOOST Trial Resets Expectations for NDV-01 and RLMD
3M ago
RLMD
Relmada Therapeutics Inc (RLMD) Q4 Earnings Cheat Sheet
PremiumPre-EarningsRelmada Therapeutics Inc (RLMD) Q4 Earnings Cheat Sheet
3M ago
RLMD
Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!
4M ago
GE
MU
Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
Premium
The Fly
Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
4M ago
MU
VZ
Why Is Relmada Therapeutics Stock (RLMD) Up Today?
PremiumMarket News
Why Is Relmada Therapeutics Stock (RLMD) Up Today?
4M ago
RLMD
Relmada Therapeutics prices 29.47M shares at $4.75 in private placement
PremiumThe Fly
Relmada Therapeutics prices 29.47M shares at $4.75 in private placement
4M ago
RLMD
Relmada Therapeutics Raises Capital, Highlights Promising NDV-01 Data
PremiumCompany Announcements
Relmada Therapeutics Raises Capital, Highlights Promising NDV-01 Data
4M ago
8K
RLMD
Relmada Therapeutics reports 12-month Phase 2 interim data for NDV-01
PremiumThe Fly
Relmada Therapeutics reports 12-month Phase 2 interim data for NDV-01
4M ago
RLMD
Relmada Therapeutics initiated with a Buy at Lucid Capital
PremiumThe FlyRelmada Therapeutics initiated with a Buy at Lucid Capital
4M ago
RLMD
Relmada Therapeutics assumed at Outperform from Market Perform at Leerink
Premium
The Fly
Relmada Therapeutics assumed at Outperform from Market Perform at Leerink
5M ago
RLMD
Relmada’s New Phase 3 Bladder Cancer Trial Adds a Fresh Catalyst to Its Pipeline
Premium
Company Announcements
Relmada’s New Phase 3 Bladder Cancer Trial Adds a Fresh Catalyst to Its Pipeline
6M ago
RLMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >